COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Nextech3D.ai Hires Ecommerce Sales Executive Madison Wynsma as Head Of its Artificial Intelligence Powered 3D Model Platform
Nextech3D.AI appoints Mady Wynsma as Head of Global Sales, leveraging her e-commerce expertise from Walmart and Kohls. The company leads in 3D and AI solutions for e-commerce -
COMMUNIQUÉ DE PRESSE
CGift AG becomes DWK Deutsche Wasserkraft AG and undergoes strategic reorganisation
CGift AG changes its name to DWK Deutsche Wasserkraft AG and reorganizes strategically, focusing on small hydro run-of-river power plants in Europe. Management Board strengthened with experienced renewable energy experts -
COMMUNIQUÉ DE PRESSE
Northern Superior Announces the Appointment of Katrina Damouni as Director Corporate Development and Melanie Pichon as Senior Exploration Geologist
Northern Superior Resources Inc. appoints Ms. Katrina Damouni as Director Corporate Development & Ms. Melanie Pichon as Senior Exploration Geologist. Company shares now trading on Frankfurt Börse under symbol D9M1. Engages MIC for investor awareness services -
COMMUNIQUÉ DE PRESSE
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Juin 2024
HF COMPANY divulgue les informations mensuelles sur le nombre total d'actions et de droits de vote. Les données au 30 juin 2024 indiquent 3 138 261 actions et 3 901 007 droits de vote -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: CGift AG appoints Henning Rath and Jan Erik Schulien as new members of the Executive Board
CGift AG appoints Henning Rath and Jan Erik Schulien as new members of the Executive Board. Delf Ness elected as Chairman of the Supervisory Board and Martin Billhardt as Deputy Chairman -
COMMUNIQUÉ DE PRESSE
oceansix future paths Provides Update on Voting Process for its Annual and Special Meeting of Shareholders Being Held on July 18, 2024
oceansix future paths Ltd. provides update on voting process for annual and special meeting of shareholders on July 18, 2024, including debt conversions and private placement approval requirements -
-
-
COMMUNIQUÉ DE PRESSE
Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
MIRA Pharmaceuticals, Inc. confirms promising findings on new oral pharmaceutical marijuana analog, MIRA-55, as a potential treatment for neurological and neuropsychiatric disorders. Comparison to THC shows enhanced efficacy and consistent anxiolytic effects
